UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

The Lancet (British edition), 2015-09, Vol.386 (9998), p.1049-1056

2015

Volltextzugriff (PDF)

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)

Lung cancer (Amsterdam, Netherlands), 2014-08, Vol.85 (2), p.306-313

2014

Volltextzugriff (PDF)

Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4157-4164

2004

Volltextzugriff (PDF)

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

Journal of clinical oncology, 2003-05, Vol.21 (9), p.1752-1759

2003

Volltextzugriff (PDF)

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

British journal of cancer, 2006-04, Vol.94 (8), p.1099-1106

2006

Volltextzugriff (PDF)

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

Annals of oncology, 2002-10, Vol.13 (10), p.1539-1549

2002

Volltextzugriff (PDF)

Effect of Single-Agent Rituximab Given at the Standard Schedule or As Prolonged Treatment in Patients With Mantle Cell Lymphoma: A Study of the Swiss Group for Clinical Cancer Research (SAKK)

Journal of clinical oncology, 2005-02, Vol.23 (4), p.705-711

2005

Volltextzugriff (PDF)

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

British journal of cancer, 2001-05, Vol.84 (10), p.1372-1376

2001

Volltextzugriff (PDF)

Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18

Journal of clinical oncology, 2005-04, Vol.23 (12), p.2831-2839

2005

Volltextzugriff (PDF)

Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability

British journal of cancer, 2005-09, Vol.93 (6), p.719-729

2005

Volltextzugriff (PDF)

Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway

Cell death and differentiation, 2002-09, Vol.9 (9), p.905-914

2002

Volltextzugriff (PDF)

Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

Swiss medical weekly, 2019-04, Vol.149, p.w20031

2019

Volltextzugriff (PDF)

Expression profiling of primary non-small cell lung cancer for target identification

Oncogene, 2002-10, Vol.21 (50), p.7749-7763

2002

Volltextzugriff (PDF)

Resilience and unmet supportive care needs in patients with cancer during early treatment: A descriptive study

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2015-10, Vol.19 (5), p.582-588

2015

Volltextzugriff (PDF)

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Annals of oncology, 2015-04, Vol.26 (4), p.709-714

2015

Volltextzugriff (PDF)

Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions

Oncogene, 2003-11, Vol.22 (54), p.8677-8687

2003

Volltextzugriff (PDF)

Origin and prognostic value of circulating KRAS mutations in lung cancer patients

Cancer letters, 2007-09, Vol.254 (2), p.265-273

2007

Volltextzugriff (PDF)

Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation

Lung cancer (Amsterdam, Netherlands), 2007-01, Vol.55 (1), p.1-14

2007

Volltextzugriff (PDF)

Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients

Journal of Oncology, 2014-01, Vol.2014 (2014), p.130-135

2014

Volltextzugriff (PDF)

The stem cell gene “inhibitor of differentiation 1” (ID1) is frequently expressed in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2011-03, Vol.71 (3), p.306-311

2011

Volltextzugriff (PDF)

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

Annals of oncology, 2008-04, Vol.19 (4), p.739-745

2008

Volltextzugriff (PDF)

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study

Annals of oncology, 2004-03, Vol.15 (3), p.511-516

2004

Volltextzugriff (PDF)

Cyclin D1 Overexpression in Bronchial Epithelia of Patients With Lung Cancer Is Associated With Smoking and Predicts Survival

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2085-2093

2003

Volltextzugriff (PDF)

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

British journal of cancer, 1996-02, Vol.73 (3), p.294-300

1996

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(152)

Publikationsform

Artikel
(204)
Berichte
(1)
Reviews
(1)

Sprache

Englisch
(174)
Deutsch
(18)
Französisch
(15)

Erscheinungsjahr

n.n

Thema

Humans
(111)
Life Sciences & Biomedicine
(90)
Science & Technology
(90)
Female
(72)
Aged
(68)
Male
(67)
Oncology
(67)
Biological And Medical Sciences
(64)
Middle Aged
(63)
Medical Sciences
(54)
Adult
(49)
Lung Neoplasms - Drug Therapy
(29)
Lung Neoplasms - Pathology
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Carcinoma, Non-Small-Cell Lung - Pathology
(26)
Chemotherapy
(26)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(25)
Aged, 80 And Over
(24)
Neoplasm Staging
(23)
Pneumology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)

Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

Effect of Single-Agent Rituximab Given at the Standard Schedule or As Prolonged Treatment in Patients With Mantle Cell Lymphoma: A Study of the Swiss Group for Clinical Cancer Research (SAKK)

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18

Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability

Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial

Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway

Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

Expression profiling of primary non-small cell lung cancer for target identification

Resilience and unmet supportive care needs in patients with cancer during early treatment: A descriptive study

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions

Origin and prognostic value of circulating KRAS mutations in lung cancer patients

Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation

Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients

The stem cell gene “inhibitor of differentiation 1” (ID1) is frequently expressed in non-small cell lung cancer

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study

Cyclin D1 Overexpression in Bronchial Epithelia of Patients With Lung Cancer Is Associated With Smoking and Predicts Survival

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

Suchergebnisse filtern